High acceptability of newborn screening for sickle cell disease among post-natal mothers in Western Kenya

John Orimbo1, Shehu Shagari Awandu1, Faith Muhonja2

  • 1Department of Biomedical and Nursing Sciences, School of Health Sciences, Jaramogi Oginga Odinga University of Science and Technology, Bondo, Kenya.

Plos One
|July 24, 2025
PubMed

Insights

Newborn screening for sickle cell disease is highly accepted by mothers in Kenya. Implementing routine screening can improve early identification and care for affected infants.

Area of Science:

  • Genetics and Hematology
  • Public Health
  • Pediatrics

Background:

  • Sickle cell disease (SCD) is a prevalent inherited blood disorder in sub-Saharan Africa, necessitating early detection.
  • Newborn screening (NBS) for SCD is recommended but underutilized in the region.
  • Kenya's 2020 policy promotes NBS for SCD, yet evidence on its acceptability is limited.

Purpose of the Study:

  • To assess the acceptability of NBS for SCD among mothers in western Kenya.
  • To identify factors influencing mothers' acceptance of NBS for SCD.

Main Methods:

  • A cross-sectional study involving 399 postnatal mothers at Homa Bay County Teaching and Referral Hospital.
  • Data collected via semi-structured questionnaires on sociodemographics, knowledge, and perceptions.
  • Sickle cell disease screening performed using the Sickle SCAN point-of-care test.

Main Results:

  • Ninety-four percent of mothers accepted NBS for SCD.
  • Maternal age (25-34 years) and formal employment were associated with lower acceptance rates.
  • Mothers in formal employment were significantly less likely to accept NBS compared to students.

Conclusions:

  • High acceptability of NBS for SCD exists among mothers in Homa Bay County.
  • The findings support the implementation of routine NBS for SCD in Kenyan healthcare facilities.
  • Targeted strategies may be needed to address lower acceptance among specific maternal demographics.